This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ensign Group (ENSG) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Fast-Aging Global Population a Boon for These 5 Stocks
by Sanghamitra Saha
The UN report says that the number of persons aged 80 or over is projected to triple by 2050. These top-ranked stocks should benefit from fast-aging global population.
Fed and Trade Pull Down U.S. Treasury Yields: 5 Safe Picks
by Nalak Das
As investors' appetite for risky assets like equities weakened to a large extent, flow of funds started shifting from equities to bond markets.
New Strong Buy Stocks for June 21st
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Acadia Healthcare Up 32% YTD: What's Driving the Rally?
by Zacks Equity Research
Acadia Healthcare's strong presence in the growing behavioral healthcare business with solid fundamentals has helped the stock to rally.
Nursing Industry Outlook Bright on Low-Cost Care & Demography
by Sapna Bagaria
An aging baby boomer population, need for low-cost care facilities and consolidation should aid the growth of the nursing industry.
Ensign Group (ENSG): Attractive Stock to Own
by Zacks Equity Research
Strong fundamentals along with changing U.S. demography are expected to favor The Ensign Group (ENSG).
New Strong Buy Stocks for May 23rd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Ensign Group (ENSG) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Will Genesis Healthcare (GEN) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Genesis Healthcare (GEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ensign Up More Than 90% in a Year: Will the Rally Continue?
by Zacks Equity Research
Strong fundamentals along with industry's growth drivers are ensuring growth at Ensign (ENSG)
Will Genesis Healthcare (GEN) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Genesis Healthcare (GEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Genesis Healthcare (GEN) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Genesis Healthcare (GEN) delivered earnings and revenue surprises of 5.88% and 0.44%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Genesis Healthcare (GEN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Genesis Healthcare (GEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com highlights: Insperity, Amedisys, Comfort Systems, Genesco and Forward Air
by Zacks Equity Research
Zacks.com highlights: Insperity, Amedisys, Comfort Systems, Genesco and Forward Air
Winning Stock Picks from the Top 5 Industries with the Biggest Job Growth
by Kevin Matras
Kevin Matras goes over how to find winning stock-picking ideas in the government's 'boring' economic reports. Highlighted stocks include NSP, AMED, FIX, GEN and FWRD.
Genesis Healthcare (GEN) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Genesis Healthcare (GEN) delivered earnings and revenue surprises of 34.62% and -2.58%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Sabra Health Care Disposes Genesis & Signature Facilities
by Zacks Equity Research
Sabra Health Care (SBRA) to use proceeds from sale of nine Genesis Healthcare facilities, and another project leased to Signature Healthcare to reduce balance under its revolving credit facility.
Acquisitions Aid Revenue Growth at Ensign Group (ENSG)
by Zacks Equity Research
Ensign Group's (ENSG) acquisitions over several past years have driven growth.
Welltower Rides on Growth Curve With Strategic Developments
by Zacks Equity Research
Welltower's (HCN) efforts to enhance its portfolio through well-thought collaborations and other strategic measures bode well for the company's long-term growth.
New Strong Sell Stocks for March 17th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for March 7th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Welltower Divests 28 Facilities to Cindat/Union Life JV
by Zacks Equity Research
Welltower Inc. (HCN) has made the announcement of closing the sale of 28 long-term/post-acute care facilities to a joint venture between Welltower, Cindat Capital Management and Union Life Insurance Co. Ltd.
Bear of the Day: Capital Senior Living Corp (CSU)
by Brian Hamilton
Occupancy for consolidated communities declined, and a spike healthcare claims caused margins to contract.